期刊
EXPERT OPINION ON PHARMACOTHERAPY
卷 9, 期 3, 页码 343-349出版社
INFORMA HEALTHCARE
DOI: 10.1517/14656566.9.3.343
关键词
dense LDL; diabetes; LDL size; pioglitazone; postprandial; rosiglitazone
Objective: To assess the effects of pioglitazone and rosiglitazone on fasting and postprandial low-density lipoprotein (LDL) size and subclasses in patients with Type 2 diabetes. Research design and methods: Nine Type 2 diabetic patients (age 61 +/- 10 years, body mass index 30 5 kg/m(2), glycosylated hemoglobin [HbA1c] 7.5 +/- 0.5%) were randomized in a crossover trial to rosiglitazone 4 mg b.i.d. or pioglitazone 45 mg/day for 12 weeks with an 8-week, wash-out period. LDL size and subclasses were determined by non-denaturing polyacrylamide gradient gel electrophoresis. A standardized breakfast was served and variables were assessed after 3 and 6 h. Results: HbA1c, insulin sensitivity (as assessed by the homeostasis model assessment) and LDL size and subclasses did not differ before treatments. Rosiglitazone and pioglitazone resulted in a similar improvement in HbA1c and insulin sensitivity. Fasting total cholesterol increased more after rosiglitazone compared with pioglitazone (p = 0.04), whereas triglycerides decreased after pioglitazone and increased after rosiglitazone (p = 0.004). Fasting LDL size similarly increased after both treatments, mainly due to increased LDL-I particles. Pioglitazone resulted in a more prominent LDL-IIA subfraction compared with rosiglitazone (p = 0.03). After 3 h, pioglitazone lead to increased LDL-IIB (p = 0.01) and decreased LDL-IVB (p = 0.05), however, after 6 h no significant changes were found. Conclusions: Pioglitazone was more effective than rosiglitazone in increasing larger LDL. concentrations (in both fasting and postprandial status) as well as in reducing levels of atherogenic small, dense particles (in postprandial status only). Whether or not these findings differentially affect the atherogenic process and the clinical endpoints such as cardiovascular events remains to be determined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据